Cargando…
MeCP2 Deficiency Leads to Loss of Glial Kir4.1
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder usually caused by mutations in methyl-CpG-binding protein 2 (MeCP2). RTT is typified by apparently normal development until 6–18 mo of age, when motor and communicative skills regress and hand stereotypies, autonomic symptoms, and seizur...
Autores principales: | Kahanovitch, Uri, Cuddapah, Vishnu A., Pacheco, Natasha L., Holt, Leanne M., Mulkey, Daniel K., Percy, Alan K., Olsen, Michelle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818552/ https://www.ncbi.nlm.nih.gov/pubmed/29464197 http://dx.doi.org/10.1523/ENEURO.0194-17.2018 |
Ejemplares similares
-
Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
por: Kahanovitch, Uri, et al.
Publicado: (2019) -
MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives
por: Cuddapah, Vishnu Anand, et al.
Publicado: (2015) -
MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats
por: Patterson, Kelsey C., et al.
Publicado: (2016) -
MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats
por: Patterson, Kelsey C., et al.
Publicado: (2016) -
MeCP2 and Chromatin Compartmentalization
por: Schmidt, Annika, et al.
Publicado: (2020)